The SIRT6 activator’s sex-specific effects shed light on the different genetic profiles of depression between men and women.

Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roivant, to expand its dermatology portfolio.

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children 2-11 years ...

At the Outsourcing in Clinical Trials Conference, US government personnel advised attendees on the transport of biologics ...

The European Commission (EC) has approved AstraZeneca ‘s Fasenra (benralizumab) as an add-on therapy for adults with ...

South Korea’s Ministry of Health and Welfare recently disclosed its proposal to revise the drug reimbursement and ...

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and ...

NETZSCH Premier Technologies has promoted Randall Smith to president. He oversees the operation of NETZSCH’s US grinding division and ...

As the retail drug pharmacy space undergoes significant change, new formats and designs that centre on the consumer are ...

UPFs have become a staple of many diets worldwide, but overconsumption is contributing to an obesity epidemic in India.

Ahead of the upcoming DSCSA November deadline, pharma companies reimagine track-and-trace to tackle the US counterfeit drug ...

The US FDA has granted orphan drug designation (ODD) to Modalis Therapeutics’ MDL-101, aimed at treating LAMA2-CMD.